Creator ranks peptides and names exercise as the only S-tier item
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedIn this video description, the creator ranks semaglutide, tirzepatide, retatrutide, BPC-157, Epitalon, MOTS-c and NAD+ and calls exercise the only S-tier item. All claims are the creator's; the video and transcript were not reviewed. [1]
The creator says semaglutide works for weight loss by activating GLP-1 receptors and making people less hungry, and warns of muscle loss without lifting weights and enough protein. [1]
The creator reports 50% more blood vessel formation in injured legs with BPC-157, but states this was in rats, and says it has only been studied in 30 humans ever. [1]
The creator says Epitalon and MOTS-c have only been shown to extend lifespan in flies, mice and rats, with no reliable human studies, and ranks exercise as the only S-tier item. [1]
Creator's weight-loss peptide tiers
The description says semaglutide (Ozempic) works for weight loss by activating GLP-1 receptors, making people less hungry. The creator warns of muscle loss without lifting weights and enough protein, and calls nausea and diarrhea quite common. The creator says lean people should not use it to get shredded, but calls it safe for overweight people when a doctor prescribes it, placing it in A tier in the right context. Tirzepatide activates two receptors, causes even less hunger and more weight loss, and is also A tier. Retatrutide activates three receptors and causes even more weight loss, but is not yet FDA approved, so the creator gives it B tier for now. [1]
BPC-157: rat vessels, few human studies
The description says BPC-157, called the wolverine peptide, claims to heal injuries. The creator reports 50% more blood vessel formation in injured legs, but states this was in rats. The creator also says it has only been studied in 30 humans ever. Anecdotes are described as strong, yet most injuries heal on their own, so it is hard to know whether BPC-157 is working. Until there is more science and quality control, the creator gives it a low C tier. [1]
Longevity peptides, NAD+ and exercise ranking
For anti-aging, the creator says Epitalon and MOTS-c have longevity mechanisms but have only been shown to extend lifespan in flies, mice and rats, with no reliable human studies and sketchy sourcing; both get F tier. NAD+ is called the most popular longevity peptide, but the creator notes it is actually a co-enzyme, not a peptide, and that the human science is weak; D tier. The last item is not technically a peptide either, but the creator puts it in S tier: exercise, said to make you look fitter and healthier, heal injuries and help you live longer. [1]
Context & limits
This is a video description only; the video and transcript were not reviewed. All rankings, safety statements and study details are the creator's claims, not independently verified here.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
makes you less hungry
that was in rats
extend lifespan in flies, mice and rats
About this video
Creator description · original textText language: English
Jeff Nippard · 2 min · Source published: 2026-10-08
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.